# Compass Therapeutics, Inc.: Form SC 13D/A, filed Mar 22, 2024

- Company: [Compass Therapeutics, Inc.](/companies/cmpx.md) (CIK 1738021)
- Form: SC 13D/A
- Filed: 2024-03-22
- Accepted by EDGAR: Mar 22, 2024, 20:59 ET
- Period: not reported
- Accession: 0000947871-24-000303
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1738021/000094787124000303/ss3178815_sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1738021/000094787124000303/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1738021/000094787124000303/ss3178815_sc13da.htm

Filed Mar 22, 2024.
Source: SEC EDGAR, the filing index for accession 0000947871-24-000303. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.